These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 26531276

  • 1. Atorvastatin might inhibit insulin resistance induced by insulin through the triglyceride-lowering role of Apolipoprotein AV.
    Zhao W, Zhao SP.
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(20):3895-903. PubMed ID: 26531276
    [Abstract] [Full Text] [Related]

  • 2. Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha.
    Huang XS, Zhao SP, Bai L, Hu M, Zhao W, Zhang Q.
    Br J Pharmacol; 2009 Oct; 158(3):706-12. PubMed ID: 19694729
    [Abstract] [Full Text] [Related]

  • 3. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
    Schaap FG, Rensen PC, Voshol PJ, Vrins C, van der Vliet HN, Chamuleau RA, Havekes LM, Groen AK, van Dijk KW.
    J Biol Chem; 2004 Jul 02; 279(27):27941-7. PubMed ID: 15090553
    [Abstract] [Full Text] [Related]

  • 4. Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents.
    Mason RP, Sherratt SC, Jacob RF.
    J Cardiovasc Pharmacol; 2016 Jul 02; 68(1):33-40. PubMed ID: 26945158
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The apolipoprotein AV gene and diurnal triglyceridaemia in normolipidaemic subjects.
    Masana L, Ribalta J, Salazar J, Fernández-Ballart J, Joven J, Cabezas MC.
    Clin Chem Lab Med; 2003 Apr 02; 41(4):517-21. PubMed ID: 12747596
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB, Akinkuolie AO, Paynter N, Glynn RJ, Ridker PM, Mora S.
    JAMA Cardiol; 2016 May 01; 1(2):136-45. PubMed ID: 27347563
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
    Grosskopf I, Baroukh N, Lee SJ, Kamari Y, Harats D, Rubin EM, Pennacchio LA, Cooper AD.
    Arterioscler Thromb Vasc Biol; 2005 Dec 01; 25(12):2573-9. PubMed ID: 16166565
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis.
    Mackey RH, Mora S, Bertoni AG, Wassel CL, Carnethon MR, Sibley CT, Goff DC.
    Diabetes Care; 2015 Apr 01; 38(4):628-36. PubMed ID: 25592196
    [Abstract] [Full Text] [Related]

  • 12. Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
    Ouguerram K, Magot T, Zaïr Y, Marchini JS, Charbonnel B, Laouenan H, Krempf M.
    J Pharmacol Exp Ther; 2003 Jul 01; 306(1):332-7. PubMed ID: 12684543
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats.
    Dorfmeister B, Brandlhofer S, Schaap FG, Hermann M, Fürnsinn C, Hagerty BP, Stangl H, Patsch W, Strobl W.
    Diabetologia; 2006 Jun 01; 49(6):1324-32. PubMed ID: 16570166
    [Abstract] [Full Text] [Related]

  • 14. Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels.
    Vaessen SF, Dallinga-Thie GM, Ross CJ, Splint LJ, Castellani LW, Rensen PC, Hayden MR, Schaap FG, Kuivenhoven JA.
    J Lipid Res; 2009 May 01; 50(5):880-4. PubMed ID: 19141870
    [Abstract] [Full Text] [Related]

  • 15. [Puerariae Lobatae Radix elevated expression levels of OB-R, IRS2, GLUT1 and GLUT2 to regulate glucose metabolism in insulin-resistance HepG2 cells].
    Li Y, Luo XX, Yan FD, Wei ZB, Tu J.
    Zhongguo Zhong Yao Za Zhi; 2017 May 01; 42(10):1939-1944. PubMed ID: 29090554
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5.
    Fruchart-Najib J, Baugé E, Niculescu LS, Pham T, Thomas B, Rommens C, Majd Z, Brewer B, Pennacchio LA, Fruchart JC.
    Biochem Biophys Res Commun; 2004 Jun 25; 319(2):397-404. PubMed ID: 15178420
    [Abstract] [Full Text] [Related]

  • 18. Association of plasma apolipoprotein AV with lipid profiles in patients with acute coronary syndrome.
    Huang XS, Zhao SP, Zhang Q, Bai L, Hu M.
    Atherosclerosis; 2009 Jun 25; 204(2):e99-102. PubMed ID: 19150068
    [Abstract] [Full Text] [Related]

  • 19. [Statin reduced triglyceride level via activating peroxisome proliferator activated receptor α and upregulating apolipoprotein A5 in hypertriglyceridemic rats].
    HUANG XS, ZHAO SP, BAI L, ZHANG Q, HU M, ZHAO W.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep 25; 38(9):809-13. PubMed ID: 21092650
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.